Viatris - VTRS Net Assets per Single Share

Viatris Inc. possesses immense authority in medicine thanks to the legacy of legendary drugs. The trend in book value per share demonstrates asset resilience, with the latest mark standing at 12.41. This stability is bolstered by a hybrid production model featuring moderate outsourcing and the active implementation of robotics in packaging and logistics processes.

Viatris Inc (VTRS): Share Book Value from 07/04/2022 to 10/28/2026

viatris.com - analytical breakdowns and key metrics (VTRS)

- price and consensus price forecast:

Price Chart Viatris Corp|VTRS - Fair Value Consensus

- market capitalization data:

Market Value Viatris Inc.|VTRS - Company Buyout Price

- book capitalization data:

Net Assets per Single Share Viatris|VTRS - Net Asset Value|Market Capitalization to Book Value Ratio viatris.com|VTRS - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital Viatris Inc.|VTRS - Long-Term Debt to Capital|Short-Term Debt to Equity Viatris|VTRS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Viatris Inc.

Fundamental company valuation:Viatris Corp - VTRS

Book value per share determines the issuer's actual financial stability through the volume of net assets. This metric is calculated as the ratio of equity to the number of shares outstanding. According to GURU.Markets data, the book value of one common share of Viatris Inc. (VTRS) currently stands at 12.41. This metric demonstrates the intrinsic value of the business stripped of market speculation. Amid intense price competition with Asian generics, such a valuation is critical for analyzing the viability of Viatris Inc.

Competitors of Viatris Inc. (VTRS)

Net Assets per Single Share Eli Lilly & Co. (LLY)|ABBV: Accounting Value of a Share|AstraZeneca PLC - Net Assets per Single Share|NVS (novartis.com) - Net Assets per Share|Net Assets per Single Share Merck MRK|Share Book Value Novo Nordisk AS|Amgen Corporation (AMGN) - Book Value per Share|Accounting Value of a Share Pfizer Corp (PFE)|Book Value per Share SNY (Sanofi)|bms.com - Book Value per Share|Net Assets per Single Share GSK Corp (GSK)|TAK: Accounting Value of a Share|TEVA (Teva) - Net Assets per Single Share|Dr. Reddy's Labs (RDY) - Accounting Value per Share|ROIV (Roivant Sciences Ltd.) - Book Value per Share|Book Value per Share zailaboratory.com (ZLAB)|Bausch Health (BHC) - Accounting Value per Share|Accounting Value of a Share Cosmos Health, Inc. (COSM)